Core Viewpoint - The rising international gold prices have led to increased attention on Zijin Mining's spin-off of its high-growth gold business, Zijin Gold International, for a Hong Kong IPO Group 1: IPO Details - Zijin Gold International's IPO has attracted 29 cornerstone investors, collectively subscribing for $1.6 billion of the offering shares [1] - Notably, the only industrial capital participating in the IPO is from Shandong Gold Mining's subsidiary, which subscribed for 3.2655 million shares, accounting for 0.94% of the total offering [1] Group 2: Key Investors - Major cornerstone investors include GIC, Hillhouse, BlackRock, and Schroders, with GIC and Hillhouse each investing $150 million, representing 4.68% of the offering shares [2] - Other significant investors include Baillie Gifford, China Pacific Insurance, and Taikang Life, each investing $60 million, representing 1.87% of the offering shares [2] Group 3: Strategic Partnerships - Shandong Gold Mining and Zijin Mining have a deep-rooted relationship, with Zijin Mining acquiring a 20% stake in Shandong Gold Mining for 4.06 billion yuan at the end of 2022 [3] - Both companies are jointly developing the largest single gold mine in China and the first offshore gold mine, with Shandong Gold Mining holding 70% and Zijin Mining 30% of the offshore gold mine [3] Group 4: Growth Potential - Zijin Gold International is projected to have significant growth, with a compound annual growth rate (CAGR) of 61.9% in net profit from 2022 to 2024, and is expected to rank ninth globally in gold reserves and eleventh in gold production by the end of 2024 [6] - The offshore gold mine is expected to achieve an annual production of over 15 tons of gold once fully operational by the end of 2027 [3]

招金矿业(01818)发布公告，于2025年9月17日，斯派柯国际有限公司(公司全资附属公司，作为投资者) 与紫金国际(作为发行人)、摩根士丹利、中信证券及中信里昂订立基石投资协议，据此，投资者有条件 同意按发售价认购投资者股份，作为国际发售一部分，该等投资者股份投资金额预计为3000万美元的等 值港元金额。 紫金国际是紫金矿业（601899）旗下专注于黄金开采、冶炼及销售的国际化平台，是全球黄金矿业中的 重要参与者。公司认为，基石投资可进一步加深公司与紫金矿业战略合作关系，对公司维持增长以及为 股东带来长期回报而言实属有利。 ...

Core Viewpoint - The company, AUX Electric (02580), is set to launch an initial public offering (IPO) from August 25 to August 28, 2025, aiming to raise approximately HKD 3.287 billion through the global sale of 207 million shares, with a price range of HKD 16.00 to 17.42 per share [1][3]. Group 1: Company Overview - AUX Electric is one of the top five air conditioning providers globally, involved in the design, research and development, production, sales, and service of both household and central air conditioning systems [1]. - The company has a significant presence in the global air conditioning market, covering over 150 countries and regions, with a market share of 7.1% as of 2024 [1]. Group 2: Financial Performance - The company has demonstrated strong revenue growth, with revenue increasing from RMB 19.528 billion in 2022 to RMB 24.832 billion in 2023 (up 27.2%), and further to RMB 29.759 billion in 2024 (up 19.8%) [2]. - Net profit also saw substantial growth, rising from RMB 1.442 billion in 2022 to RMB 2.487 billion in 2023 (up 72.5%), and to RMB 2.91 billion in 2024 (up 17.0%) [2]. - The net profit margin for the years 2022, 2023, and 2024 was recorded at 7.4%, 10.0%, and 9.8% respectively, with a margin of 10.2% for the three months ending March 31, 2025 [2]. Group 3: Use of Proceeds - Approximately 20% of the net proceeds from the IPO are expected to be allocated to global research and development, 50% for upgrading smart manufacturing systems and supply chain management, 20% for enhancing sales and distribution channels, and 10% for working capital and general corporate purposes [3].

Core Viewpoint - The increasing interest of cornerstone investors, particularly local state-owned enterprises (SOEs), in Hong Kong IPOs is highlighted, with a significant rise in their participation and investment amounts over recent years [5][20]. Group 1: Cornerstone Investors' Role - In 2025, 85.7% of Hong Kong IPOs involved cornerstone investors, a significant increase from 26.5% in 2018, indicating a shift from being a luxury to a necessity for companies [9][11]. - The participation of local SOEs in cornerstone investments has surged, with 16 local SOEs investing a total of 2.557 billion HKD in 13 companies in the first half of 2025, marking a 33.3% increase in participants and a 65.9% increase in investment amount compared to the previous year [15][20]. Group 2: Financial Performance of IPOs - Companies with cornerstone investors saw a median stock price increase of 15.16% and an average increase of 49.08% six months post-IPO, while those without cornerstone investors experienced a median decline of 20.30% [11][12]. - Among the 42 IPOs in 2025 that included cornerstone investors, 86.1% saw their stock prices rise, with 21 companies experiencing gains exceeding 50% [13]. Group 3: Local SOEs' Strategic Interests - Local SOEs are increasingly motivated by industrial objectives, seeking to enhance local industry ecosystems through their investments in IPOs [22]. - Historical data shows that while there have been few cases of companies relocating their registered addresses, many have established production lines or branches in the regions of their investors, indicating a strategic alignment between capital and local industry development [22][24]. Group 4: Case Study - CATL - CATL's IPO in 2025 was the largest globally, attracting 23 cornerstone investors, including significant investments from local SOEs, which have been part of a long-term strategic partnership [25][26]. - The collaboration with local SOEs has allowed CATL to secure stable supplies of critical resources, enhancing its production capabilities and contributing to local economic growth [26].

Core Viewpoint - The article highlights the significant role cornerstone investors play in the Hong Kong stock market, particularly during the A+H listing wave this year, with a notable increase in both the number of A+H companies and the total funds raised compared to the previous year [1][2]. Group 1: A+H Listing Trends - In 2023, 10 A-share companies completed A+H listings in Hong Kong, raising a total of 886.24 billion HKD, marking the highest fundraising record for this period [1]. - The number of A+H companies has increased significantly from zero in the same period last year, indicating a growing trend in international capital's recognition of the Hong Kong market [1][2]. Group 2: Cornerstone Investors' Participation - Leading companies like CATL attracted a substantial number of international cornerstone investors, with 23 participating and international placements accounting for 92.5% of the total [1][4]. - In contrast, non-leading companies saw lower participation from international investors, reflecting a preference for established firms with strong market positions [2][4]. Group 3: Characteristics of Cornerstone Investors - Cornerstone investors are more inclined to invest in leading enterprises due to their strong industry positions and stable profitability, which instills greater confidence [3][4]. - The participation of cornerstone investors often involves mutual benefits, where companies may offer incentives or future collaboration commitments to secure investment [7]. Group 4: International Investor Dynamics - International investors show a higher participation rate in leading A+H companies, particularly in sectors like technology and biomedicine, which are perceived as having growth potential and stability [5][6]. - The decision-making process for international capital prioritizes the industry position and long-term market outlook of companies, assessing investment returns based on these factors [5]. Group 5: Market Outlook - The attractiveness of the Hong Kong stock market is expected to persist, with ongoing trends of A-share companies listing in Hong Kong and increasing southbound capital inflows impacting the valuation of A+H shares [8]. - Recent data indicates that 21.5% of the 251 IPOs filed this year are A-share companies, with a notable increase in international investor participation in Hong Kong IPOs [8].

Core Viewpoint - The Hong Kong Stock Exchange (HKEX) is experiencing a significant surge in IPO activities, with multiple companies successfully listing and attracting substantial investments, indicating a revitalized market confidence and a robust pipeline for future listings [2][7][10]. Group 1: Recent IPO Activities - On July 9, five companies including Lens Technology and Geek+ collectively listed on the HKEX, creating a lively atmosphere and showcasing the exchange's appeal [2][4]. - Lens Technology, with a market capitalization exceeding 110 billion HKD, completed its IPO in just 100 days, marking a record speed for the HKEX [4]. - Geek+, a robotics unicorn, achieved a market valuation of 22 billion HKD upon listing, highlighting the growing interest in technology-driven companies [4][5]. Group 2: Market Trends and Statistics - Over 40 companies successfully completed IPOs on the HKEX in the first half of the year, raising a total of 1,067 billion HKD, a dramatic increase of 688.56% compared to the previous year [7]. - Notable IPOs include CATL, which reached a market value of 1.3 trillion HKD, and other major players like Heng Rui Medicine and Hai Tian Flavor, each raising over 10 billion HKD [7]. - The HKEX is preparing for over 100 upcoming IPOs, with around 200 applications currently received, indicating a strong pipeline for future listings [7][10]. Group 3: Investor Sentiment and Market Dynamics - There is a renewed confidence in the HKEX, with institutional investors actively seeking opportunities to list companies, contrasting sharply with previous years' challenges [10][11]. - In the first half of the year, 36 out of 42 listed companies had cornerstone investors, accounting for 43.7% of total IPO fundraising, demonstrating strong backing from major investment firms [10]. - The successful performance of cornerstone investors in recent listings has further fueled interest in the HKEX as a viable platform for capital raising [11].

Group 1 - The cornerstone investment in the Hong Kong IPO market has become increasingly active, with over 40% of the 43 IPOs in the first half of the year attracting more than five cornerstone investors, a significant increase compared to the same period last year [1] - The willingness of medium to long-term funds to participate in cornerstone investments has risen, as institutions seek to "lock in" quality assets amid improving market liquidity [1][2] - The consumer and healthcare sectors are particularly favored by cornerstone investors, with notable examples including the Thai coconut water brand attracting 11 cornerstone investors who collectively subscribed approximately $3.95 million, representing about 26% of the shares [2] Group 2 - The diversity of cornerstone investors in Hong Kong IPOs has increased, including foreign sovereign funds, global asset management giants, and domestic platforms, indicating a more varied investment landscape [3][4] - Foreign investors are particularly focused on industry leaders, with significant investments in companies like Heng Rui Pharmaceutical and Ningde Times, highlighting a trend towards selecting high-growth, profitable enterprises [4] - The Hong Kong market is positioned as a key platform for connecting quality Chinese enterprises with global capital, driven by the dual demand for "A+H listings" and the return of quality overseas Chinese assets [5]

Group 1: Fund Industry Developments - Multiple public funds are actively purchasing newly issued floating-rate funds, indicating strong market interest and support from fund companies [1] - The new floating-rate funds are designed to anchor performance benchmarks, incentivizing fund managers to enhance investment capabilities and research systems [1] - As of June 3, 440 A-share listed companies have announced share buybacks, with 78 companies initiating new buyback plans in May alone [1] Group 2: Wealth Management and Financial Services - The wealth management industry is experiencing a "fee reduction wave," with some products offering management fees as low as 0.01% per year, translating to just 1 yuan for a 10,000 yuan investment [2] - Major banks are adjusting their car loan commission structures, reducing high rebate rates to enhance service quality and market competitiveness [2] Group 3: Pharmaceutical and Biotechnology - Bayer's prostate cancer drug Nubeqa has received FDA approval based on positive results from a Phase 3 trial, showing a 46% reduction in the risk of disease progression or death [3] Group 4: IPO and Market Activity - There has been a significant increase in foreign capital participation in Hong Kong IPOs, with 15 out of 27 companies this year attracting foreign cornerstone investors, compared to only 3 last year [5] - Shenzhen Handback Technology Group's IPO faced challenges, with its stock price dropping nearly 30% from the initial offering price shortly after listing [6][7] Group 5: Corporate Financing and Strategic Moves - China Ping An plans to issue zero-coupon convertible bonds totaling 11.765 billion HKD to support its business development and capital needs [10] - United Optoelectronics intends to acquire 100% of Changyi Optoelectronics through a share issuance, with the final transaction details pending [8] Group 6: Market Performance - The US stock market saw all three major indices rise, with the Dow Jones increasing by 0.51% and Nvidia leading the gains in the tech sector [11]

Group 1 - The number of foreign institutions participating as cornerstone investors in Hong Kong IPOs has significantly increased in 2023, with 15 out of 27 companies listing on the Hong Kong Stock Exchange attracting foreign investment, compared to only 3 out of 21 in the same period last year [1][5] - Foreign investors are primarily interested in sectors such as new consumption, new energy, and pharmaceuticals, indicating a recognition of the long-term value of China's core assets [1][5] - Notable companies that have attracted foreign cornerstone investors include CATL, Mijia Group, and Hengrui Medicine, among others [1][3] Group 2 - CATL's IPO on May 20 was one of the largest in recent years, attracting 23 cornerstone investors, including global sovereign wealth funds and major asset management firms [2][3] - The trend of increased foreign participation in Hong Kong IPOs is driven by a growing demand for international capital allocation and the benefits of China's industrial upgrade [5] - Foreign investors are focusing on high-growth sectors, with a preference for leading companies in the new economy, aiming for long-term financial returns [2][3] Group 3 - The new consumption sector has seen significant foreign investment, with Mijia Group raising $200 million from five cornerstone investors, including M&G plc [3][4] - The pharmaceutical sector is also attracting foreign interest, with companies like InnoCare Pharma securing cornerstone investors with international industry backgrounds, enhancing market confidence and long-term value [4][5] - Foreign institutions participating as cornerstone investors provide not only capital but also strategic collaboration opportunities, which can aid in technology transfer and resource integration [4][5]

Company Overview - The company, 新琪安 (02573), is a producer of food-grade glycine and sucralose, with over 20 years of industry experience [1] - It ranks first in the global food-grade glycine manufacturing industry based on sales volume and revenue for 2023, holding approximately 5.1% and 3.1% of the global market share respectively [1] - The company's food-grade glycine accounted for about 0.31% of the global food additive market by sales volume in 2023 [1] IPO Details - The company plans to conduct an IPO from May 30 to June 5, 2025, offering 10,585,400 H-shares, with 10% allocated for public sale in Hong Kong and 90% for international sale, plus an additional 15% over-allotment option [1] - The expected price range for the shares is HKD 18.9 to 20.9 per share, with shares anticipated to be listed on June 10, 2025 [1] Use of Proceeds - Assuming a share price of HKD 19.9 and no exercise of the over-allotment option, the net proceeds from the global offering are estimated to be approximately HKD 174.3 million [2] - About 21.3% of the proceeds will be allocated to the construction of a production line for isomaltitol at a factory in Thailand, with an expected annual capacity of 15,000 tons [2] - Approximately 55.3% will be used over the next two years for the production of algal dietary fiber and serine [2] - Around 13.4% will be invested in enhancing research and development capabilities [2] - About 10.0% will be utilized for working capital and general corporate purposes [2] Strategic Partnerships - The company has entered into cornerstone investment agreements with The Reynold Lemkins Group (Asia) Limited and 合赢香江控股有限公司, agreeing to subscribe for shares at the offer price, with a total investment not exceeding HKD 60 million [2]